Company: ABBV
Filing Date: 2025-02-14
Form Type: 10-K
Source: 0001551152-25-000020
Chunk: 279

Company: AbbVie Inc.
Filing Date: 2025-02-14
Form: 10-K
Item: Item 7
Chunk 279
---
.5)%(18.5)%Total$3,347 $3,596 $4,568 (6.9)%(21.3)%(6.9)%(21.3)%VenclextaUnited States$1,234 $1,087 $1,009 13.5 %7.8 %13.5 %7.8 %International1,349 1,201 1,000 12.3 %20.1 %18.0 %22.3 %Total$2,583 $2,288 $2,009 12.9 %13.9 %15.9 %15.0 %Elahere(a)United States$477 $— $— n/mn/mn/mn/mInternational2 — — n/mn/mn/mn/mTotal$479 $— $— n/mn/mn/mn/mEpkinlyCollaboration revenues$118 $28 $— >100.0 %n/m>100.0 %n/mInternational28 3 — >100.0 %n/m>100.0 %n/mTotal$146 $31 $— >100.0 %n/m>100.0 %n/mAestheticsBotox CosmeticUnited States$1,682 $1,670 $1,654 0.7 %1.0 %0.7 %1.0 %International1,038 1,012 961 2.7 %5.3 %6.7 %9.7 %Total$2,720 $2,682 $2,615 1.4 %2.6 %2.9 %4.2 %Juvederm CollectionUnited States$469 $519 $548 (9.6)%(5.4)%(9.6)%(5.4)%International708 859 880 (17.6)%(2.4)%(13.4)%1.9 %Total$1,177 $1,378 $1,428 (14.6)%(3.6)%(12.0)%(0.9)%Other AestheticsUnited States$1,118 $1,060